Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueTax ProvisionsTax Rate
Others
Ratios

Acadia Healthcare Company (ACHC) Equity Income (2016 - 2020)

Historic Equity Income for Acadia Healthcare Company (ACHC) over the last 6 years, with Q1 2020 value amounting to $48.4 million.

  • Acadia Healthcare Company's Equity Income rose 20040.7% to $48.4 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$426.4 million, marking a year-over-year decrease of 25814.46%. This contributed to the annual value of -$174.2 million for FY2019, which is 27656.61% down from last year.
  • Latest data reveals that Acadia Healthcare Company reported Equity Income of $48.4 million as of Q1 2020, which was up 20040.7% from -$348.6 million recorded in Q4 2019.
  • In the past 5 years, Acadia Healthcare Company's Equity Income registered a high of $423.2 million during Q4 2017, and its lowest value of -$348.6 million during Q4 2019.
  • In the last 5 years, Acadia Healthcare Company's Equity Income had a median value of -$3.6 million in 2016 and averaged $17.9 million.
  • In the last 5 years, Acadia Healthcare Company's Equity Income plummeted by 29644.96% in 2016 and then soared by 46809.4% in 2017.
  • Over the past 5 years, Acadia Healthcare Company's Equity Income (Quarter) stood at $74.5 million in 2016, then skyrocketed by 468.09% to $423.2 million in 2017, then decreased by 27.96% to $304.9 million in 2018, then crashed by 214.33% to -$348.6 million in 2019, then soared by 113.87% to $48.4 million in 2020.
  • Its Equity Income was $48.4 million in Q1 2020, compared to -$348.6 million in Q4 2019 and -$60.3 million in Q3 2019.